Can a simple test spot heart damage in cancer survivors?
NCT ID NCT05201014
First seen Jun 26, 2026 · Last updated Aug 11, 2026 · Updated 2 times
Summary
This study looks at whether a special ECG and a blood test can find early signs of heart weakness in adult cancer survivors who had certain chemotherapy. Researchers will check how well these tests work compared to standard heart imaging. The goal is to gather information needed to create a national screening program for long-term heart monitoring.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple, cost-effective screening program to catch heart problems early in cancer survivors.
- What could go wrong
- This is a small pilot study, so results may not apply to all survivors. The tests might not be accurate enough for widespread use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Can a personalized exercise program boost recovery in cancer survivors?
- Could muscle loss predict blood cancer outcomes?
- Smartwatch could spot nerve damage before it starts
- Could sitting up make radiation therapy more comfortable?